Howard Robin

Howard Robin

Director Ejecutivo en NEKTAR THERAPEUTICS .

Fortuna: 4 M $ al 30/06/2026

73 años
Health Technology
Commercial Services
Consumer Services

Perfil

Howard W.
Robin
is President, Chief Executive Officer & Director at Nektar Therapeutics since 2007.
Formerly, Mr. Robin was President, Chief Executive Officer & Director at Sirna Therapeutics, Inc. from 2001 to 2006.
From 1984 to 2001, held roles at Berlex, Inc., including Director-Business Planning & Development from 1987 to 2001 and Vice President & General Manager from 1991 to 2001.
Also served as Director at Acologix, Inc., Biotechnology Innovation Organization, and The Bay Area Bioscience Association.
Worked as Senior Associate at Arthur Andersen LLP.
Served as Trustee at Fairleigh Dickinson University.
Education includes an undergraduate degree from Fairleigh Dickinson University, conferred in 1974.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
17/06/2026 55.073 ( 0,16 % ) 4 M $ 30/06/2026

Cargos activos de Howard Robin

EmpresasCargoInicio
NEKTAR THERAPEUTICS Director Ejecutivo 01/01/2007

Antiguos cargos conocidos de Howard Robin.

EmpresasCargoFin
Director Ejecutivo 01/11/2006
Corporate Officer/Principal -
Berlex Laboratories, Inc.
Director Financiero/CFO 01/01/1991
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Ver el detalle de la experiencia de Howard Robin.

Formación de Howard Robin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

70

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Health Technology

Berlex Laboratories, Inc.